Status:
COMPLETED
Cost-effectiveness of FDG-PET
Lead Sponsor:
University of Sao Paulo
Collaborating Sponsors:
Netherlands: Ministry of Health, Welfare and Sports
Conditions:
Oncologic Patients
Eligibility:
All Genders
13+ years
Brief Summary
Evaluation of cost-effectiveness of FDG-PET for the public health system in Brazil.
Detailed Description
To provide detailed information about cost and effectiveness of FDG-PET in multiple oncological diseases, such as Lymphoma, lung cancer and esophageal cancer.
Eligibility Criteria
Inclusion
- Cancer
Exclusion
- Other malignancy
- Uncontrolled Diabetes
- Pregnancy
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01438164
Start Date
June 1 2005
End Date
September 1 2011
Last Update
September 21 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.